CN Patent

CN112521366A — 作为葡糖神经酰胺合酶的抑制剂的无定型和结晶形式的Genz 112638半酒石酸盐

Assigned to Genzyme Corp · Expires 2021-03-19 · 5y expired

What this patent protects

公开了由以下结构式代表的化合物的半酒石酸盐： (式I半酒石酸盐)，其可用于药学应用。式(I)半酒石酸盐的特定单晶型的特征在于多种性质和物理测量。此外也公开了制备结晶的式(I)半酒石酸盐的方法、以及用它抑制受试者的葡糖神经酰胺合酶或降低受试者的鞘糖脂浓度，从而治疗多种疾病。也描述了药物组合物。

USPTO Abstract

公开了由以下结构式代表的化合物的半酒石酸盐： (式I半酒石酸盐)，其可用于药学应用。式(I)半酒石酸盐的特定单晶型的特征在于多种性质和物理测量。此外也公开了制备结晶的式(I)半酒石酸盐的方法、以及用它抑制受试者的葡糖神经酰胺合酶或降低受试者的鞘糖脂浓度，从而治疗多种疾病。也描述了药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN112521366A
Jurisdiction
CN
Classification
—
Expires
2021-03-19
Drug substance claim
No
Drug product claim
No
Assignee
Genzyme Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.